BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 23962649)

  • 1. Α2 GABAA receptor sub-units in the ventral hippocampus and α5 GABAA receptor sub-units in the dorsal hippocampus mediate anxiety and fear memory.
    McEown K; Treit D
    Neuroscience; 2013 Nov; 252():169-77. PubMed ID: 23962649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mineralocorticoid receptors in the medial prefrontal cortex and hippocampus mediate rats' unconditioned fear behaviour.
    McEown K; Treit D
    Horm Behav; 2011 Nov; 60(5):581-8. PubMed ID: 21889941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivation of the dorsal or ventral hippocampus with muscimol differentially affects fear and memory.
    McEown K; Treit D
    Brain Res; 2010 Sep; 1353():145-51. PubMed ID: 20647005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissociation of the anxiolytic-like effects of Avpr1a and Avpr1b receptor antagonists in the dorsal and ventral hippocampus.
    Engin E; Treit D
    Neuropeptides; 2008 Aug; 42(4):411-21. PubMed ID: 18508119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the dorsal and ventral hippocampus in fear and memory of a shock-probe experience.
    McEown K; Treit D
    Brain Res; 2009 Jan; 1251():185-94. PubMed ID: 19061870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporary inhibition of dorsal or ventral hippocampus by muscimol: distinct effects on measures of innate anxiety on the elevated plus maze, but similar disruption of contextual fear conditioning.
    Zhang WN; Bast T; Xu Y; Feldon J
    Behav Brain Res; 2014 Apr; 262():47-56. PubMed ID: 24211449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivation of the medial prefrontal cortex with the GABAA receptor agonist muscimol increases open-arm activity in the elevated plus-maze and attenuates shock-probe burying in rats.
    Shah AA; Sjovold T; Treit D
    Brain Res; 2004 Nov; 1028(1):112-5. PubMed ID: 15518648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of hippocampal GABA(A) and muscarinic receptors in consolidation of context memory and context-shock association in contextual fear conditioning: a double dissociation study.
    Chang SD; Liang KC
    Neurobiol Learn Mem; 2012 Jul; 98(1):17-24. PubMed ID: 22543193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dorsal and ventral hippocampal cholinergic systems modulate anxiety in the plus-maze and shock-probe tests.
    Degroot A; Treit D
    Brain Res; 2002 Sep; 949(1-2):60-70. PubMed ID: 12213300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TPA023 [7-(1,1-dimethylethyl)-6-(2-ethyl-2H-1,2,4-triazol-3-ylmethoxy)-3-(2-fluorophenyl)-1,2,4-triazolo[4,3-b]pyridazine], an agonist selective for alpha2- and alpha3-containing GABAA receptors, is a nonsedating anxiolytic in rodents and primates.
    Atack JR; Wafford KA; Tye SJ; Cook SM; Sohal B; Pike A; Sur C; Melillo D; Bristow L; Bromidge F; Ragan I; Kerby J; Street L; Carling R; Castro JL; Whiting P; Dawson GR; McKernan RM
    J Pharmacol Exp Ther; 2006 Jan; 316(1):410-22. PubMed ID: 16183706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time course of dorsal and ventral hippocampal involvement in the expression of trace fear conditioning.
    Cox D; Czerniawski J; Ree F; Otto T
    Neurobiol Learn Mem; 2013 Nov; 106():316-23. PubMed ID: 23747568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of GABA ligands injected into the nucleus accumbens shell on fear/anxiety-like and feeding behaviours in food-deprived rats.
    Lopes AP; Ganzer L; Borges AC; Kochenborger L; Januário AC; Faria MS; Marino-Neto J; Paschoalini MA
    Pharmacol Biochem Behav; 2012 Mar; 101(1):41-8. PubMed ID: 22130445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for the participation of peripheral α5 subunit-containing GABAA receptors in GABAA agonists-induced nociception in rats.
    Bravo-Hernández M; Feria-Morales LA; Torres-López JE; Cervantes-Durán C; Delgado-Lezama R; Granados-Soto V; Rocha-González HI
    Eur J Pharmacol; 2014 Jul; 734():91-7. PubMed ID: 24726872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ANI inactivation: unconditioned anxiolytic effects of anisomycin in the ventral hippocampus.
    Greenberg A; Ward-Flanagan R; Dickson CT; Treit D
    Hippocampus; 2014 Nov; 24(11):1308-16. PubMed ID: 24910137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dorsal versus ventral hippocampal contributions to trace and contextual conditioning: differential effects of regionally selective NMDA receptor antagonism on acquisition and expression.
    Czerniawski J; Ree F; Chia C; Otto T
    Hippocampus; 2012 Jul; 22(7):1528-39. PubMed ID: 22180082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anxiogenic effect of CCK8s in the ventral hippocampus of rats: possible involvement of GABA(A) receptors.
    Hajizadeh Moghaddam A; Hosseini RS; Roohbakhsh A
    Pharmacol Rep; 2012; 64(1):45-53. PubMed ID: 22580519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The anxiolytic-like effects of allopregnanolone vary as a function of intracerebral microinfusion site: the amygdala, medial prefrontal cortex, or hippocampus.
    Engin E; Treit D
    Behav Pharmacol; 2007 Sep; 18(5-6):461-70. PubMed ID: 17762514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ventral hippocampus and fear conditioning in rats. Different anterograde amnesias of fear after tetrodotoxin inactivation and infusion of the GABA(A) agonist muscimol.
    Bast T; Zhang WN; Feldon J
    Exp Brain Res; 2001 Jul; 139(1):39-52. PubMed ID: 11482842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioural pharmacology of the α5-GABA
    Gacsályi I; Móricz K; Gigler G; Wellmann J; Nagy K; Ling I; Barkóczy J; Haller J; Lambert JJ; Szénási G; Spedding M; Antoni FA
    Neuropharmacology; 2017 Oct; 125():30-38. PubMed ID: 28694097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GABAA α5 subunit-containing receptors do not contribute to reversal of inflammatory-induced spinal sensitization as indicated by the unique selectivity profile of the GABAA receptor allosteric modulator NS16085.
    de Lucas AG; Ahring PK; Larsen JS; Rivera-Arconada I; Lopez-Garcia JA; Mirza NR; Munro G
    Biochem Pharmacol; 2015 Feb; 93(3):370-9. PubMed ID: 25542996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.